Global Bulk Drug Intermediates Market Size By Type of Intermediates, By End-Use Industry, By Geographic Scope And Forecast

Report ID: 380823|No. of Pages: 202

product image

Global Bulk Drug Intermediates Market Size By Type of Intermediates, By End-Use Industry, By Geographic Scope And Forecast

Report ID: 380823|Published Date: Feb 2024|No. of Pages: 202|Base Year for Estimate: 2023|Format:   Report available in PDF formatReport available in Excel Format

Bulk Drug Intermediates Market Size and Forecast

Bulk Drug Intermediates Market size was valued at USD 29.7 Billion 2023 and is projected to reach USD 51.6 Billion by 2030, growing at a CAGR of 5.5% during the forecasted period 2024 to 2030.

Bulk Drug Intermediates Market is estimated to grow at a CAGR of 5.5% & reach US$ 51.6 Bn by the end of 2030

Global Bulk Drug Intermediates Market Drivers

The growth and development of the Bulk Drug Intermediates Market is attributed to certain main market drivers. These factors have a big impact on how Bulk Drug Intermediates are demanded and adopted in different sectors. Several of the major market forces are as follows:

  • Growth of the Pharmaceutical Industry: The bulk drug intermediates market is significantly influenced by the expansion of the pharmaceutical industry. The need for intermediates used in medication production rises as pharmaceutical companies create new drugs and diversify their product lines.
  • Growing Drug Development Activities: The need for bulk drug intermediates is being driven up by the continued research and development of new drugs, particularly in the fields of oncology, cardiovascular disease, and infectious illnesses.
  • Trends in Outsourcing: A lot of pharmaceutical businesses contract with specialized manufacturers to produce their bulk medication intermediates. Efficiency gains, a concentration on core capabilities, and cost concerns may be the driving forces behind this trend.
  • Tight Regulations: Tight regulations pertaining to pharmaceutical manufacturing frequently result in a greater dependence on premium bulk medication intermediates. Intermediates that satisfy or beyond regulatory requirements may be given priority by businesses.
  • Cost-Efficiency and Supply Chain Optimization: For pharmaceutical companies, optimizing the pharmaceutical supply chain and producing drugs at a reasonable cost are essential factors. Bulk medication intermediates contribute to reduced costs and a more efficient supply chain.
  • Growth of Contract Manufacturing Organizations (CMOs): The bulk drug intermediates market is expected to develop as a result of the rise in CMOs, which are companies that produce drug intermediates.
  • Emerging Markets and Globalization: Greater demand for bulk drug intermediates, particularly in areas where the pharmaceutical sector is expanding, is a result of the globalization of pharmaceutical supply chains and the creation of new markets.
  • Technological Developments: Improvements in manufacturing technologies, process optimization, and synthetic chemistry can boost the productivity of bulk drug intermediate production, attracting the interest of pharmaceutical companies.
  • Emphasis on Specialty and High-Value Intermediates: Specialized and superior bulk drug intermediates are frequently needed in light of the pharmaceutical industry’s growing emphasis on specialty and high-value pharmaceuticals.
  • Preferential Shift to Green Chemistry: The market for ecologically friendly bulk pharmacological intermediates may be driven by a growing consciousness of environmental sustainability and a preference for green chemistry techniques.

Global Bulk Drug Intermediates Market Restraints

The Global Bulk Drug Intermediates Market has a lot of room to grow, but there are several industry limitations that could make it harder for it to do so. It’s imperative that industry stakeholders comprehend these difficulties. Among the significant market limitations are:

  • Regulatory Challenges: Producers of bulk drug intermediates may face difficulties due to strict regulations and compliance concerns. Production schedules and market access may be impacted by modifications to regulations or delays in approval processes.
  • Price Volatility of Raw Materials: Variations in the pricing of chemicals and solvents, two raw materials used to produce bulk medication intermediates, can have an effect on a manufacturer’s total cost structure and profitability.
  • Supply Chain Disruptions: Any number of unanticipated occurrences, such as pandemics, natural catastrophes, or geopolitical issues, can cause disruptions in the global supply chain that can effect production schedules and raw material availability.
  • Quality Control Challenges: Pharmaceutical producers must maintain consistent quality in the production of bulk drug intermediates. Any breaches in quality control may result in legal problems, product recalls, and harm to one’s reputation.
  • Intense Competition: There are many manufacturers fighting for market share in the bulk pharma intermediates business, which may be extremely competitive. Pricing and profit margins may be under pressure from fierce competition.
  • Shifts in production Practices: The demand for particular kinds of bulk drug intermediates may be impacted by modifications in pharmaceutical production techniques, such as the adoption of continuous manufacturing or improvements in synthetic pathways.
  • Patent Expirations: The market for certain intermediates may be impacted by a drop in demand for bulk drug intermediates connected to a particular drug as a result of a patent expiration.
  • Environmental and Sustainability Concerns: Growing awareness of environmental and sustainability issues could influence the bulk drug intermediate production processes by creating a desire for more sustainable and environmentally friendly manufacturing methods.
  • Complexity of Synthesis: Certain medication intermediates may require specialist knowledge and tools to complete their complex synthesis processes. One of the main obstacles, especially for smaller firms, is the difficulty of synthesis.
  • Global Economic Factors: Uncertainties or economic downturns may have an effect on pharmaceutical spending, which may in turn affect the market for bulk drug intermediates. In reaction to economic difficulties, businesses may reduce production or postpone starting new initiatives.

Global Bulk Drug Intermediates Market Segmentation Analysis

The Global Bulk Drug Intermediates Market is segmented on the basis of Type of Intermediates, End-Use Industry, And Geography.

Bulk Drug Intermediates Market Segmentation Analysis

By Type of Intermediates

  • Chemical Intermediates: A division according to the type of intermediate (amino acids, alcohols, or acids, for example).
  • Biological Intermediates: This category focuses on intermediates that come from biological sources or that are produced through biotechnological methods.

By End-Use Industry

  • Pharmaceutical Companies: Based on the companies that manufacture drugs using bulk drug intermediates directly, there is a segmentation.
  • Contract Manufacturing Organizations (CMOs): These organizations concentrate on intermediates made for pharmaceutical corporations by outside manufacturers.

By Geography

  • North America
  • Asia-Pacific
  • Latin America
  • Middle East & Africa
  • Europe

Key Players

The major players in the Bulk Drug Intermediates Market are:

  • Aceto Corporation (U.S.)
  • BASF SE (Germany)
  • Chiracon GmbH (Germany)
  • Dishman Group (India)
  • Green Vision Life Sciences (India)
  • Lonza Group (Switzerland)
  • Sanofi SAIS (France)
  • Vertellus Holdings LLC (U.S.)
  • Yin-sheng Bio-tech Co., Ltd. (China)

Report Scope

REPORT ATTRIBUTESDETAILS
STUDY PERIOD

2020-2030

BASE YEAR

2023

FORECAST PERIOD

2024-2030

HISTORICAL PERIOD

2020-2022

UNIT

Value (USD Billion)

KEY COMPANIES PROFILED

Aceto Corporation (U.S.), BASF SE (Germany), Chiracon GmbH (Germany), Dishman Group (India), Green Vision Life Sciences (India), Lonza Group (Switzerland), Sanofi SAIS (France), Vertellus Holdings LLC (U.S.), Yin-sheng Bio-tech Co., Ltd. (China)

SEGMENTS COVERED

Type of Intermediates, End-Use Industry, And Geography.

CUSTOMIZATION SCOPE

Free report customization (equivalent up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope.

Top Trending Reports:

Global Chemical Detergent Market Size And Forecast

Global Chlorinated Polyolefin Adhesion Promoters Market Size And Forecast

Research Methodology of Verified Market Research:

Research Methodology of VMR

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at Verified Market Research.

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.

Frequently Asked Questions

Bulk Drug Intermediates Market was valued at USD 29.7 billion 2023 and is projected to reach USD 51.6 billion by 2030, growing at a CAGR of 5.5% during the forecasted period 2024 to 2030.

Growing pharmaceutical industry, increasing demand for generic drugs, cost-effective production, and rising prevalence of chronic diseases propel the Bulk Drug Intermediates Market.

The major players in the global Bulk Drug Intermediates Market are Aceto Corporation (U.S.), BASF SE (Germany), Chiracon GmbH (Germany), Dishman Group (India), Green Vision Life Sciences (India), Lonza Group (Switzerland), Sanofi SAIS (France), Vertellus Holdings LLC (U.S.), Yin-sheng Bio-tech Co., Ltd. (China)

The Global Bulk Drug Intermediates Market is segmented on the basis of Type of Intermediates, End-Use Industry, And Geography.

The sample report for the Bulk Drug Intermediates Market can be obtained on demand from the website. Also, the 24*7 chat support & direct call services are provided to procure the sample report.

1. Introduction
• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary
• Key Findings
• Market Overview
• Market Highlights

3. Market Overview
• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter’s Five Forces Analysis

4 Bulk Drug Intermediates Market, By type of Intermediates:
• Chemical Intermediates
• Biological Intermediates

5. Bulk Drug Intermediates Market, By End-Use Industry:
• Pharmaceutical Companies
• Contract Manufacturing Organizations (CMOs)

6. Regional Analysis
• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

7. Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

8. Competitive Landscape

• Key Players
• Market Share Analysis

9. Company Profiles
• Aceto Corporation (U.S.)
• BASF SE (Germany)
• Chiracon GmbH (Germany)
• Dishman Group (India)
• Green Vision Life Sciences (India)
• Lonza Group (Switzerland)
• Sanofi SAIS (France)
• Vertellus Holdings LLC (U.S.)
• Yin-sheng Bio-tech Co., Ltd. (China)

10. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

11. Appendix

• List of Abbreviations
• Sources and References

Report Research Methodology

Research methodology

Verified Market Research uses the latest researching tools to offer accurate data insights. Our experts deliver the best research reports that have revenue generating recommendations. Analysts carry out extensive research using both top-down and bottom up methods. This helps in exploring the market from different dimensions.

This additionally supports the market researchers in segmenting different segments of the market for analysing them individually.

We appoint data triangulation strategies to explore different areas of the market. This way, we ensure that all our clients get reliable insights associated with the market. Different elements of research methodology appointed by our experts include:

Exploratory data mining

Market is filled with data. All the data is collected in raw format that undergoes a strict filtering system to ensure that only the required data is left behind. The leftover data is properly validated and its authenticity (of source) is checked before using it further. We also collect and mix the data from our previous market research reports.

All the previous reports are stored in our large in-house data repository. Also, the experts gather reliable information from the paid databases.

expert data mining

For understanding the entire market landscape, we need to get details about the past and ongoing trends also. To achieve this, we collect data from different members of the market (distributors and suppliers) along with government websites.

Last piece of the ‘market research’ puzzle is done by going through the data collected from questionnaires, journals and surveys. VMR analysts also give emphasis to different industry dynamics such as market drivers, restraints and monetary trends. As a result, the final set of collected data is a combination of different forms of raw statistics. All of this data is carved into usable information by putting it through authentication procedures and by using best in-class cross-validation techniques.

Data Collection Matrix

PerspectivePrimary ResearchSecondary Research
Supplier side
  • Fabricators
  • Technology purveyors and wholesalers
  • Competitor company’s business reports and newsletters
  • Government publications and websites
  • Independent investigations
  • Economic and demographic specifics
Demand side
  • End-user surveys
  • Consumer surveys
  • Mystery shopping
  • Case studies
  • Reference customer

Econometrics and data visualization model

data visualiztion model

Our analysts offer market evaluations and forecasts using the industry-first simulation models. They utilize the BI-enabled dashboard to deliver real-time market statistics. With the help of embedded analytics, the clients can get details associated with brand analysis. They can also use the online reporting software to understand the different key performance indicators.

All the research models are customized to the prerequisites shared by the global clients.

The collected data includes market dynamics, technology landscape, application development and pricing trends. All of this is fed to the research model which then churns out the relevant data for market study.

Our market research experts offer both short-term (econometric models) and long-term analysis (technology market model) of the market in the same report. This way, the clients can achieve all their goals along with jumping on the emerging opportunities. Technological advancements, new product launches and money flow of the market is compared in different cases to showcase their impacts over the forecasted period.

Analysts use correlation, regression and time series analysis to deliver reliable business insights. Our experienced team of professionals diffuse the technology landscape, regulatory frameworks, economic outlook and business principles to share the details of external factors on the market under investigation.

Different demographics are analyzed individually to give appropriate details about the market. After this, all the region-wise data is joined together to serve the clients with glo-cal perspective. We ensure that all the data is accurate and all the actionable recommendations can be achieved in record time. We work with our clients in every step of the work, from exploring the market to implementing business plans. We largely focus on the following parameters for forecasting about the market under lens:

  • Market drivers and restraints, along with their current and expected impact
  • Raw material scenario and supply v/s price trends
  • Regulatory scenario and expected developments
  • Current capacity and expected capacity additions up to 2027

We assign different weights to the above parameters. This way, we are empowered to quantify their impact on the market’s momentum. Further, it helps us in delivering the evidence related to market growth rates.

Primary validation

The last step of the report making revolves around forecasting of the market. Exhaustive interviews of the industry experts and decision makers of the esteemed organizations are taken to validate the findings of our experts.

The assumptions that are made to obtain the statistics and data elements are cross-checked by interviewing managers over F2F discussions as well as over phone calls.

primary validation

Different members of the market’s value chain such as suppliers, distributors, vendors and end consumers are also approached to deliver an unbiased market picture. All the interviews are conducted across the globe. There is no language barrier due to our experienced and multi-lingual team of professionals. Interviews have the capability to offer critical insights about the market. Current business scenarios and future market expectations escalate the quality of our five-star rated market research reports. Our highly trained team use the primary research with Key Industry Participants (KIPs) for validating the market forecasts:

  • Established market players
  • Raw data suppliers
  • Network participants such as distributors
  • End consumers

The aims of doing primary research are:

  • Verifying the collected data in terms of accuracy and reliability.
  • To understand the ongoing market trends and to foresee the future market growth patterns.

Industry Analysis Matrix

Qualitative analysisQuantitative analysis
  • Global industry landscape and trends
  • Market momentum and key issues
  • Technology landscape
  • Market’s emerging opportunities
  • Porter’s analysis and PESTEL analysis
  • Competitive landscape and component benchmarking
  • Policy and regulatory scenario
  • Market revenue estimates and forecast up to 2027
  • Market revenue estimates and forecasts up to 2027, by technology
  • Market revenue estimates and forecasts up to 2027, by application
  • Market revenue estimates and forecasts up to 2027, by type
  • Market revenue estimates and forecasts up to 2027, by component
  • Regional market revenue forecasts, by technology
  • Regional market revenue forecasts, by application
  • Regional market revenue forecasts, by type
  • Regional market revenue forecasts, by component

Bulk Drug Intermediates Market

report-detail

Download Sample Report

View More Reports